Clinical trial
Prevention of Osteoporosis in Men With Prostate Cancer
NCT00048841 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00048841 |
|---|---|
| Title | Prevention of Osteoporosis in Men With Prostate Cancer |
| Official title | Prevention of Osteoporosis in Men With Prostate Cancer |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer, Osteoporosis, Hypogonadism |
| Intervention type | Drug |
| Interventions | alendronate |
| Enrollment | 112 |
| Start date | May 1, 2002 |
| Completion | Dec 1, 2005 |
| First posted | Nov 13, 2002 |
| Last update posted | Mar 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: